Hitting the target: where now for precision medicines?

Today (10th April 2018) WA Health has launched a new insight report on precision medicines, Hitting the target: Where now for precision medicines? In recent years precision medicines have become increasingly common as our understanding of disease, particularly cancer, has become more advanced. For example, lung cancer, once described as a single disease, is nowRead more

Appraising vaccines in the UK – what’s worth a shot?

Ever since the first vaccination at the end of the 18th century (using fluid from a cowpox blister no less), the debate about vaccines has remained highly complex and emotive. The petition in the last parliament calling for wider access to the Meningitis B vaccination in the UK is the third largest petition the parliamentaryRead more

Being led up the garden Pathway: Is there something more to the Accelerated Access Pathway?

The dust has now settled on the Government’s long-long-¬awaited response to the Accelerated Access Review (AAR), which was published on Friday. The key details of the response are relatively well known. The Government is setting up an Accelerated Access Pathway (AAP) to streamline the route to market for around five “breakthrough” treatments every year. TheRead more